Assessment of therapeutic options for reducing alkali burn-induced corneal neovascularization and inflammation

被引：49

作者：

Bakunowicz-Lazarczyk, Alina ^{[1
]}

Urban, Beata ^{[1
]}

机构：

[1] Med Univ Bialystok, Dept Pediat Ophthalmol & Strabismus, Waszyngtona 17, PL-15274 Bialystok, Poland

来源：

ADVANCES IN MEDICAL SCIENCES | 2016年 / 61卷 / 01期

关键词：

Corneal neovascularization; Alkali burn; Treatment; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MICROVASCULAR ENDOTHELIAL-CELLS; MOLECULAR-WEIGHT HEPARIN; ACTIVATED RECEPTOR-GAMMA; MESENCHYMAL STEM-CELLS; OCULAR CHEMICAL BURNS; BEVACIZUMAB AVASTIN; ASCORBIC-ACID; GROWTH-FACTOR; RAT MODEL;

D O I：

10.1016/j.advms.2015.10.003

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

100103 [病原生物学]; 100218 [急诊医学];

摘要：

This article aims to review and provide the current knowledge of the possibilities of topical treatment of corneal neovascularization due to alkali burns, evidenced by laboratory experiments, in vitro studies, and clinical trials published in the specialized literature. Authors present clinically relevant treatment of corneal neovascularization used in clinical practice, potential antiangiogenic topical therapeutics against corneal neovascularization, which are under investigation, and anti-angiogenic gene-therapy. (C) 2015 Medical University of Bialystok. Published by Elsevier Sp. z o.o. All rights reserved.

引用

收藏

页码：101 / 112

页数：12

相关论文

共 127 条

[1]

Clinical correlates of common corneal neovascular diseases: a literature review [J].

Abdelfattah, Nizar Saleh ;

Amgad, Mohamed ;

Zayed, Amira A. ;

Salem, Hamdy ;

Elkhanany, Ahmed E. ;

Hassein, Heba ;

Abd El-Baky, Nawal .

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (01) :182-193

[2]

Antitumor/Antiestrogenic Effect of the Chemokine Interferon Inducible Protein 10 (IP-10) Involves Suppression of VEGF Expression in Mammary Tissue [J].

Aronica, Susan M. ;

Raiber, Lisa ;

Hanzly, Michael ;

Kisela, Caroline .

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (02) :83-91

[3]

Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug [J].

Asai, T ;

Nakagami, T ;

Mochizuki, M ;

Hata, N ;

Tsuchiya, T ;

Hotta, Y .

CORNEA, 2006, 25 (02) :224-227

[4]

Corneal Neovascularization as a Risk Factor for Graft Failure and Rejection after Keratoplasty An Evidence-Based Meta-analysis [J].

Bachmann, Bjorn ;

Taylor, Rod S. ;

Cursiefen, Claus .

OPHTHALMOLOGY, 2010, 117 (07) :1300-U42

[5]

Case of corneal melting associated with the use of topical Nepafenac [J].

Bekendam, Peter D. ;

Narvaez, Julio ;

Agarwal, Madhu .

CORNEA, 2007, 26 (08) :1002-1003

[6]

Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis [J].

Berdugo, M ;

Andrieu-Soler, C ;

Doat, M ;

Courtois, Y ;

BenEzra, D ;

Behar-Cohen, F .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (11) :4072-4078

[7]

NK1 Receptor Antagonists as a New Treatment for Corneal Neovascularization [J].

Bignami, Fabio ;

Giacomini, Chiara ;

Lorusso, Anna ;

Aramini, Andrea ;

Rama, Paolo ;

Ferrari, Giulio .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (10) :6783-6794

[8]

Bevacizumab (Avastin) eye drops inhibit corneal neovascularization [J].

Bock, Felix ;

Koenig, Yanyan ;

Kruse, Friedrich ;

Baier, Martin ;

Cursiefen, Claus .

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (02) :281-284

[9]

Epidermal growth factor receptor in corneal damage: update and new insights from recent reports [J].

Bonafonte Marquez, E. ;

De Ortueta, D. ;

Bonafonte Royo, S. ;

Martinez-Carpio, Pedro A. .

CUTANEOUS AND OCULAR TOXICOLOGY, 2011, 30 (01) :7-14

[10]

RGTA-based matrix therapy in severe experimental corneal lesions: Safety and efficacy studies [J].

Brignole-Baudouin, F. ;

Warnet, J. M. ;

Barritault, D. ;

Baudouin, C. .

JOURNAL FRANCAIS D OPHTALMOLOGIE, 2013, 36 (09) :740-747

← 1 2 3 4 5 6 7 8 9 10 →